<VariationArchive VariationID="1691287" VariationName="NM_153704.6(TMEM67):c.479_480del (p.Phe160fs)" VariationType="Deletion" Accession="VCV001691287" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-08" DateCreated="2022-06-11" MostRecentSubmission="2022-12-31">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1683766" VariationID="1691287">
      <GeneList>
        <Gene Symbol="TMEM67" FullName="transmembrane protein 67" GeneID="91147" HGNC_ID="HGNC:28396" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="93754844" stop="93832653" display_start="93754844" display_stop="93832653" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="94767071" stop="94831461" display_start="94767071" display_stop="94831461" Strand="+" />
          </Location>
          <OMIM>609884</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_153704.6(TMEM67):c.479_480del (p.Phe160fs)</Name>
      <CanonicalSPDI>NC_000008.11:93763911:TTTT:TT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="93763912" stop="93763913" display_start="93763912" display_stop="93763913" variantLength="2" positionVCF="93763911" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="94776140" stop="94776141" display_start="94776140" display_stop="94776141" variantLength="2" positionVCF="94776139" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>F160fs</ProteinChange>
      <ProteinChange>F79fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.94776142_94776143del" Assembly="GRCh37">
            <Expression>NC_000008.10:g.94776142_94776143del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.93763914_93763915del" Assembly="GRCh38">
            <Expression>NC_000008.11:g.93763914_93763915del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009190.1" sequenceAccession="NG_009190" sequenceVersion="1" change="g.14071_14072del">
            <Expression>NG_009190.1:g.14071_14072del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001142301.1" sequenceAccession="NM_001142301" sequenceVersion="1" change="c.236_237del">
            <Expression>NM_001142301.1:c.236_237del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001135773.1" sequenceAccession="NP_001135773" sequenceVersion="1" change="p.Phe79fs">
            <Expression>NP_001135773.1:p.Phe79fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_153704.6" sequenceAccession="NM_153704" sequenceVersion="6" change="c.479_480del" MANESelect="true">
            <Expression>NM_153704.6:c.479_480del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_714915.3" sequenceAccession="NP_714915" sequenceVersion="3" change="p.Phe160fs">
            <Expression>NP_714915.3:p.Phe160fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_024522.2" sequenceAccession="NR_024522" sequenceVersion="2" change="n.500_501del">
            <Expression>NR_024522.2:n.500_501del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_688" sequenceAccession="LRG_688">
            <Expression>LRG_688:g.14071_14072del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_688t2" sequenceAccession="LRG_688t2">
            <Expression>LRG_688t2:c.236_237del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_688p2" sequenceAccession="LRG_688p2" change="p.Phe79fs">
            <Expression>LRG_688p2:p.Phe79fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="868404889" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_153704.6(TMEM67):c.479_480del (p.Phe160fs) AND Meckel syndrome, type 3" Accession="RCV002254385" Version="5">
        <ClassifiedConditionList TraitSetID="372">
          <ClassifiedCondition DB="MedGen" ID="C1846357">Meckel syndrome, type 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_153704.6(TMEM67):c.479_480del (p.Phe160fs) AND multiple conditions" Accession="RCV002505897" Version="1">
        <ClassifiedConditionList TraitSetID="48006">
          <ClassifiedCondition DB="MedGen" ID="C2673874">Bardet-Biedl syndrome 14</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C5435651">COACH syndrome 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1853153">Joubert syndrome 6</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1846357">Meckel syndrome, type 3</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3150796">Nephronophthisis 11</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1865794">RHYNS syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-24" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-21" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-06-11" MostRecentSubmission="2022-12-31">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <DescriptionHistory Dated="2022-12-31">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="372" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2832" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Meckel syndrome, type 3</ElementValue>
                <XRef ID="MONDO:0011821" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MECKEL-GRUBER SYNDROME, TYPE 3</ElementValue>
                <XRef Type="MIM" ID="607361" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">TMEM67</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">MKS3</ElementValue>
                <XRef Type="MIM" ID="607361" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8744" />
                <XRef ID="8744" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21368913</ID>
              </Citation>
              <XRef ID="564" DB="Orphanet" />
              <XRef ID="C1846357" DB="MedGen" />
              <XRef ID="MONDO:0011821" DB="MONDO" />
              <XRef Type="MIM" ID="607361" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="48006" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="821" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">COACH syndrome 1</ElementValue>
                <XRef ID="MONDO:0008996" DB="MONDO" />
                <XRef ID="MONDO:0800103" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1410" />
                <XRef ID="1410" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15153" />
                <XRef ID="15153" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21448235</ID>
              </Citation>
              <XRef ID="1454" DB="Orphanet" />
              <XRef ID="C5435651" DB="MedGen" />
              <XRef ID="MONDO:0800103" DB="MONDO" />
              <XRef Type="MIM" ID="216360" DB="OMIM" />
            </Trait>
            <Trait ID="2500" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Joubert syndrome 6</ElementValue>
                <XRef ID="MONDO:0012539" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">JBTS6</ElementValue>
                <XRef Type="MIM" ID="610688" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">TMEM67</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15494" />
                <XRef ID="15494" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Classic Joubert syndrome (JS) is characterized by three primary findings: A distinctive cerebellar and brain stem malformation called the molar tooth sign (MTS). Hypotonia. Developmental delays. Often these findings are accompanied by episodic tachypnea or apnea and/or atypical eye movements. In general, the breathing abnormalities improve with age, truncal ataxia develops over time, and acquisition of gross motor milestones is delayed. Cognitive abilities are variable, ranging from severe intellectual disability to normal. Additional findings can include retinal dystrophy, renal disease, ocular colobomas, occipital encephalocele, hepatic fibrosis, polydactyly, oral hamartomas, and endocrine abnormalities. Both intra- and interfamilial variation are seen.</Attribute>
                <XRef ID="NBK1325" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301500</ID>
                <ID Source="BookShelf">NBK1325</ID>
              </Citation>
              <XRef ID="475" DB="Orphanet" />
              <XRef ID="C1853153" DB="MedGen" />
              <XRef ID="MONDO:0012539" DB="MONDO" />
              <XRef Type="MIM" ID="610688" DB="OMIM" />
            </Trait>
            <Trait ID="2832" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Meckel syndrome, type 3</ElementValue>
                <XRef ID="MONDO:0011821" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MECKEL-GRUBER SYNDROME, TYPE 3</ElementValue>
                <XRef Type="MIM" ID="607361" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">TMEM67</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">MKS3</ElementValue>
                <XRef Type="MIM" ID="607361" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8744" />
                <XRef ID="8744" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21368913</ID>
              </Citation>
              <XRef ID="564" DB="Orphanet" />
              <XRef ID="C1846357" DB="MedGen" />
              <XRef ID="MONDO:0011821" DB="MONDO" />
              <XRef Type="MIM" ID="607361" DB="OMIM" />
            </Trait>
            <Trait ID="8926" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Bardet-Biedl syndrome 14</ElementValue>
                <XRef ID="MONDO:0014442" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BBS14</ElementValue>
                <XRef Type="MIM" ID="615991" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16038" />
                <XRef ID="16038" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301537</ID>
                <ID Source="BookShelf">NBK1363</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2010">
                <ID Source="pmc">3061994</ID>
              </Citation>
              <XRef ID="110" DB="Orphanet" />
              <XRef ID="C2673874" DB="MedGen" />
              <XRef ID="MONDO:0014442" DB="MONDO" />
              <XRef Type="MIM" ID="615991" DB="OMIM" />
            </Trait>
            <Trait ID="9715" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis 11</ElementValue>
                <XRef ID="Nephronophthisis+11/8979" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013302" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">TMEM67</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">NPHP11</ElementValue>
                <XRef Type="MIM" ID="613550" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-LÃ¸ken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18080" />
                <XRef ID="18080" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="84081" DB="Orphanet" />
              <XRef ID="C3150796" DB="MedGen" />
              <XRef ID="MONDO:0013302" DB="MONDO" />
              <XRef Type="MIM" ID="613550" DB="OMIM" />
            </Trait>
            <Trait ID="4107" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">RHYNS syndrome</ElementValue>
                <XRef ID="RHYNS+syndrome/6316" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011202" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Retinitis pigmentosa, HYpopituitarism, Nephronophthisis, and mild Skeletal dysplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Retinitis pigmentosa syndrome</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9681" />
                <XRef ID="9681" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="140976" DB="Orphanet" />
              <XRef ID="C1865794" DB="MedGen" />
              <XRef ID="MONDO:0011202" DB="MONDO" />
              <XRef Type="MIM" ID="602152" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4948447" SubmissionDate="2022-05-31" DateLastUpdated="2022-06-11" DateCreated="2022-06-11">
        <ClinVarSubmissionID localKey="chr8:94776140delTT" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002525527" DateUpdated="2022-06-11" DateCreated="2022-06-11" Type="SCV" Version="1" SubmitterName="Diagnostics Services (NGS), CSIR - Centre For Cellular And Molecular Biology" OrgID="507246" OrganizationCategory="other" OrgAbbreviation="AIC-CCMB" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.479_480del variant is not present in publicly available population databases like 1000 Genomes, Exome Aggregation Consortium (ExAC), Genome Aggregation Database (gnomAD) and Indian Exome Database. The heterozygous state of the variant is present in Exome Variant Server (EVS), at a very low frequency. The variant is not present in our in-house exome database. The variant was not previously reported to Clinvar, Human Genome Mutation Database (HGMD) and/or OMIM databases, in any affected individuals. In-silico pathogenicity prediction programs like MutationTaster2, CADD, Varsome etc. predicted this variant to be likely deleterious. The variant creates a frameshift at the 160th amino acid position of the wild type transcript, that creates a premature stop codon at the 173th amino acid position of the altered transcript, that may either results into a truncated protein or non-sense mediated decay of the mRNA.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <NamePlatform>Novaseq</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Purpose>discovery</Purpose>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TMEM67" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153704.6:c.479_480del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607361" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>The c.479_480del variant was identified as a part of carrier screening in a couple.</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB11548002</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5468467" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_153704.6:c.479_480del|OMIM:216360;602152;607361;610688;613550;615991" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002817086" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153704.6:c.479_480del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="216360" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="602152" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607361" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610688" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613550" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615991" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5468467" TraitType="Disease" MappingType="XRef" MappingValue="615991" MappingRef="OMIM">
        <MedGen CUI="C2673874" Name="Bardet-Biedl syndrome 14" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5468467" TraitType="Disease" MappingType="XRef" MappingValue="216360" MappingRef="OMIM">
        <MedGen CUI="C5435651" Name="COACH syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5468467" TraitType="Disease" MappingType="XRef" MappingValue="602152" MappingRef="OMIM">
        <MedGen CUI="C1865794" Name="RHYNS syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5468467" TraitType="Disease" MappingType="XRef" MappingValue="607361" MappingRef="OMIM">
        <MedGen CUI="C1846357" Name="Meckel syndrome, type 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4948447" TraitType="Disease" MappingType="XRef" MappingValue="607361" MappingRef="OMIM">
        <MedGen CUI="C1846357" Name="Meckel syndrome, type 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5468467" TraitType="Disease" MappingType="XRef" MappingValue="610688" MappingRef="OMIM">
        <MedGen CUI="C1853153" Name="Joubert syndrome 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5468467" TraitType="Disease" MappingType="XRef" MappingValue="613550" MappingRef="OMIM">
        <MedGen CUI="C3150796" Name="Nephronophthisis 11" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

